Summary & Overview
HCPCS G9288: Documentation of Reason for Not Reporting Histologic Type
HCPCS Level II code G9288 documents clinician justification for not reporting a histological type or the nsclc-nos classification, capturing cases where tissue findings or clinical history preclude standard histologic categorization. Nationally, this code matters because it records clinically valid exceptions to reporting conventions that can affect cancer registry classification, pathology reporting, and downstream payment or quality measure workflows. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what G9288 represents, the clinical contexts in which it is used (for example, solitary fibrous tumors or other documented medical reasons preventing histologic classification), and how documentation-focused codes fit into pathology and outpatient diagnostic workflows. The publication provides benchmarks and policy context where available, outlines common sites of service and service type, and summarizes implications for coding and billing processes. Data not available in the input is noted where applicable. This summary is intended for national audiences involved in coding, pathology documentation, compliance, and payer relations.
Billing Code Overview
HCPCS Level II code G9288 documents the medical reason(s) for not reporting the histological type or nsclc-nos classification, with an explanatory statement (for example, a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons). This code captures clinician documentation explaining why standard histologic categorization or the designation nsclc-nos was not reported.
-
Service type: Pathology/clinical documentation of histology classification exception
-
Typical site of service: Hospital outpatient department, pathology laboratory, or other diagnostic/ambulatory settings where histologic classification and documentation occur
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of lung malignancy undergoes tissue sampling for a suspected recurrence. The surgical pathology team receives a pleural-based mass specimen that on gross and limited microscopic evaluation cannot be definitively subclassified as non-small cell lung carcinoma (NSCLC) or a specific histologic type due to prior treatment effects, scant tissue, or an alternative tumor (e.g., solitary fibrous tumor) in the setting of prior NSCLC. The pathologist documents the medical reason(s) for not reporting the histological type or nsclc-nos classification in the pathology report, including explicit explanation (for example, prior neoadjuvant therapy causing treatment effect, insufficient viable tumor, extensive necrosis, or competing diagnosis). Clinical workflow: the surgeon obtains the specimen in the operating room or interventional suite, the specimen is routed to surgical pathology, the pathologist reviews clinical history and prior pathology, performs available ancillary testing as appropriate (immunohistochemistry, molecular studies when feasible), and records the formal reason(s) for omission of histologic subclassification in the final pathology report to support use of billing code G9288. Typical site of service: hospital outpatient pathology department, hospital inpatient pathology service, or independent pathology laboratory associated with surgical or interventional procedures.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|